|
[Related PubMed/MEDLINE]
Total Number of Papers: 9
|
|
|
|
|
[Display Entries]
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: HIF1A-AS2 |
| Long Form |
: hypoxia-inducible factor 1 alpha-antisense RNA 2 |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2021 |
HIF1A-AS2 Promotes the Proliferation and Metastasis of Gastric Cancer Cells Through miR-429/PD-L1 Axis. |
CCK-8, GC, miR-429, PD-L1, qRT-PCR |
| 2 |
2020 |
Inhibition of long noncoding RNA HIF1A-AS2 confers protection against atherosclerosis via ATF2 downregulation. |
ECs, HCAECs, HFD, ICAM-1, IL-1beta, IL-6, lncRNAs, MCP-1, SMCs, TNF-alpha, VCAM-1 |
| 3 |
2019 |
KCNQ1OT1, HIF1A-AS2 and APOA1-AS are promising novel biomarkers for diagnosis of coronary artery disease. |
APOA1-AS, CAD, KCNQ1OT1, lncRNAs, PBMCs |
| 4 |
2019 |
The inhibitive effect of sh-HIF1A-AS2 on the proliferation, invasion, and pathological damage of breast cancer via targeting miR-548c-3p through regulating HIF-1alpha/VEGF pathway in vitro and vivo. |
BC, HIF-1alpha, VEGF |
| 5 |
2018 |
The long noncoding RNA HIF1A-AS2 facilitates cisplatin resistance in bladder cancer. |
CIS, HMGA1, lncRNA |
| 6 |
2017 |
A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers. |
lncRNAs, NTNBC, TNBC, UCA1 |
| 7 |
2016 |
Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer. |
lncRNAs, shRNA |
| 8 |
2016 |
The Long Non-coding RNA HIF1A-AS2 Facilitates the Maintenance of Mesenchymal Glioblastoma Stem-like Cells in Hypoxic Niches. |
GBM, GSCs, lncRNAs |
| 9 |
2015 |
Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis. |
GC, lncRNAs |
|
A Search Service for Abbreviation / Long Form
